Literature DB >> 8319473

Advances in the management of refractory status epilepticus.

T P Bleck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8319473     DOI： 10.1097/00003246-199307000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  6 in total

1.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

2.  Prolonged coma from refractory status epilepticus.

Authors:  Saqib I Dara; Lori A Tungpalan; Edward M Manno; Vivien H Lee; Kevin G Moder; Mark T Keegan; Jimmy R Fulgham; Daniel R Brown; Keith H Berge; Francis X Whalen; Tuhin K Roy
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Continuous midazolam infusion as treatment of status epilepticus.

Authors:  R L Koul; G Raj Aithala; A Chacko; R Joshi; M Seif Elbualy
Journal:  Arch Dis Child       Date:  1997-05       Impact factor: 3.791

Review 4.  The current state of treatment of status epilepticus.

Authors:  Lawrence J Hirsch; Jan Claassen
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 5.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

Authors:  M Bebin; T P Bleck
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

6.  Prolonged refractory status epilepticus following acute traumatic brain injury: a case report of excellent neurological recovery.

Authors:  Adam D Peets; Luc R Berthiaume; Sean M Bagshaw; Paolo Federico; Christopher J Doig; David A Zygun
Journal:  Crit Care       Date:  2005-10-27       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.